Safety profile of duloxetine vs. paroxetine

被引：0
|
作者：
Tran, PV
Lu, Y
Martynov, O
Xu, J
Detke, MJ
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
[3] McLean Hosp, Dept Psychiat, Belmont, MA 02178 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源：
EUROPEAN PSYCHIATRY | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：214S / 215S
页数：2
相关论文
共 50 条
  • [1] Safety profile of duloxetine versus paroxetine
    Sipowicz, S
    Tran, P
    Lu, YL
    Martynov, O
    Detke, M
    JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 : S132 - S132
  • [2] Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain
    Irving, G.
    Tanenberg, R. J.
    Raskin, J.
    Risser, R. C.
    Malcolm, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (09) : 1130 - 1140
  • [3] THE SAFETY PROFILE OF PAROXETINE
    BOYER, WF
    BLUMHARDT, CL
    JOURNAL OF CLINICAL PSYCHIATRY, 1992, 53 : 61 - 66
  • [4] The hepatic safety profile of duloxetine: a review
    McIntyre, Roger S.
    Panjwani, Zilomi D.
    Nguyen, Ha T.
    Woldeyohannes, Hanna
    Alsuwaidan, Mohammad
    Soczynska, Joanna K.
    Lourenco, Maria T.
    Konarski, Jakub Z.
    Kennedy, Sidney H.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (03) : 281 - 285
  • [5] Safety vs. Safety
    Braun, Matt
    Biomedical Instrumentation and Technology, 2013, 47 (05):
  • [6] The safety and tolerability of duloxetine vs. placebo in the treatment of elderly patients with major depressive disorder (MDD)
    Raskin, J
    Wiltse, C
    Dinkel, J
    Xu, J
    Katona, C
    Gandhi, P
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A47 - A47
  • [7] Safety profile of enantiomers vs. racemic mixtures: it's the same?
    Caillet, Celine
    Chauvelot-Moachon, Laurence
    Montastruc, Jean-Louis
    Bagheri, Haleh
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (05) : 886 - 889
  • [8] Duloxetine vs. placebo in the treatment of elderly patients with MDD
    Raskin, J
    Wiltse, C
    Dinkel, J
    Siegel, A
    Sheikh, J
    Xu, J
    Rotz, B
    Perahia, D
    Mohs, R
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 346 - 347
  • [9] Duloxetine vs. placebo in the treatment of elderly patients with MDD
    Raskin, J
    Wiltse, C
    Dinkel, J
    Siegel, A
    Sheikh, J
    Xu, J
    Rotz, B
    Mohs, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S437 - S438
  • [10] Duloxetine vs. placebo in patients with painful diabetic neuropathy
    Goldstein, DJ
    Lu, YL
    Detke, MJ
    Lee, TC
    Iyengar, S
    PAIN, 2005, 116 (1-2) : 109 - 118
12345